Amivantamab for Named Patient Import

Amivantamab for Indian Patients

Amivantamab is a very advanced and recently launched medication, approved by FDA for the management Non–Small Cell Lung Cancer (NSCLC). Amivantamab in India is also recommended by the Medical Oncologists. This is specifically indicated for adult patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations. Developed and promoted by Janssen Pharmaceuticals, Amivantamab is marketed by the trade name - Rybrevant.

Amivantamab or Rybrevant in India is not marketed or promoted by the domestic sources. It is because Amivantamab in India is not yet registered. But, this will not be a limiting factor for patients looking for advanced options. Official channels of import are available for the same. It is available in one strength as of now. Rybrevant 350mg/7mL (50mg/mL) single-dose vial is the commercially available option. Rybrevant price and other details of procurement can be sorted based on the Named Patient import provisions. Patients can seek an individual permit for importing lifesaving medicines for personal use.

Amivantamab in India? Get help from Experts.

If you are looking for Amivantamab price or Rybrevant price in India, you can take professional assistance. Our team is experienced in assisting Indian patients. We not only recommend you the trusted sources with expertise in importing medicines, but also help you with due procedures. There are necessary legal documents that should be in the right order. You can’t take chances with a few complex procedures. You will find us more proactive and approachable when you interact with us.

Reach us - nhs@noelbiotech.com or + 91 9677010046 / + 91 9929277766.